Discussing the Unmet Clinical Needs in 2 Special CLL Patient Groups | Silvia Deaglio, MD | EHA 2024

Discussing the Unmet Clinical Needs in 2 Special CLL Patient Groups | Silvia Deaglio, MD | EHA 2024
Outcomes in High-Risk Subgroups After Ibrutinib and Venetoclax for CLL | Ryan Jacobs, MD | EHA 2024